Goldman Sachs’s Viveon Health Acquisition Corp. VHAQ Stock Holding History
Bought
Maintained
Sold
Other funds holding VHAQ
MI
SCM
PAMP
FTCM
GCL
PC
MSU
SFM
CIM
Goldman Sachs's VHAQ Position: Q1 2022 in Review
Goldman Sachs sold out of Viveon Health Acquisition Corp. (VHAQ) in Q1 2022, closing a stake of 287,864 shares — an estimated $2.88M sold.
Goldman Sachs first reported a position in VHAQ in Q1 2021 and held it in 4 quarters. The position peaked at $5.18M in Q3 2021. 27 funds tracked by Wall St. Rank hold VHAQ as of Q1 2022.
- Goldman Sachs reported no remaining Viveon Health Acquisition Corp. position as of Q1 2022 after selling out during the quarter.
- Goldman Sachs sold 287,864 Viveon Health Acquisition Corp. shares in Q1 2022, an estimated $2.88M.
- Goldman Sachs first reported a position in Viveon Health Acquisition Corp. in Q1 2021 and held it in 4 quarters.
- Goldman Sachs's Viveon Health Acquisition Corp. position peaked at $5.18M in Q3 2021.
- 27 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. as of Q1 2022.
Based on Goldman Sachs's 13F filing for Q1 2022, filed 16 May 2022.